Inside the Lab Industry

Resurgence of COVID-19 Cases Threatens to Derail Recovery of Core Business

Back on July 1, the perception was that the demand for COVID-19 testing was falling off faster than predicted. The silver lining to this cloud was the stronger than expected recovery of core … [Read more...]

Inside the Lab Industry

COVID-19 Continues Driving Growth but in a New Way as Core Revenues Rebound

The earnings narrative for Q1 is essentially the combination of growing COVID-19 revenues, albeit at a slightly slower pace than the previous quarter, and the continued recovery of non-coronavirus … [Read more...]

Increasing Revenue

New Colorectal Cancer Screening Guidelines Are a Windfall for Exact Sciences, Cologuard

If you held stock in Exact Sciences on May 17, chances are you went to bed happy on May 18. It was on May 18 that a U.S. government taskforce officially announced a change in its guidelines for … [Read more...]

Inside the Lab Industry

COVID-19 Surge Lifts Overall Molecular Point of Care Testing Market to $900 Million

To the uninitiated, the term molecular point-of-care (POC) testing might sound like an oxymoron. After all, the science of molecular microbiology is all about detecting targeted bits of microbial … [Read more...]

Inside the Lab Industry

COVID-19 Drives Unprecedented but Ultimately Unsustainable Growth

As strange as it may sound, the COVID-19 pandemic has driven unprecedented revenue growth in the diagnostics industry. The fourth quarter of 2020 not only continued but accelerated the climb in … [Read more...]

DX Earnings Report

Q3 Creates the Perfect Storm of Sustained COVID-19 Tailwinds and Diminishing Headwinds

July through September 2020 was a remarkable quarter for most diagnostics firms. In fact, it was the closest thing to a perfect storm for earnings. Pandemic tailwinds drove massive revenues for firms … [Read more...]

Economic Trends

Labs Lost Less & Will Recover More than Other Healthcare Sectors, Says New Report

Although it’s not exactly “Happy Days Are Here Again,” a new S&P report is predicting that the healthcare sector has seen the worst of the COVID-19 pandemic and won’t have to go through “a return … [Read more...]

DX Earnings Report

Q2 Revenues Slide but By Less than Wall Street Expected

As expected, the COVID-19 pandemic took a tremendous bite out of lab company earnings in the second quarter. However, the losses were largely below expectations, significantly below in many cases. And … [Read more...]

Test Utilization

Supplies Shortages Continue to Bedevil COVID-19 Testing Efforts

What was true at the beginning of the public health emergency remains true today: laboratories simply cannot obtain the supplies they need to deliver desperately needed COVID-19 molecular testing in a … [Read more...]

DX Earnings Report

Strong Q1 Earnings Belie the True Financial Devastation of COVID-19

The bad news is that COVID-19 is very, very bad for business; the good news—sort  of—is that the pandemic had just the last few weeks of March to wreak havoc on 2020 Q1 earnings reports. And even that … [Read more...]